Search Tag: renal diseases

2024 10 Oct

  Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with renal diseases, is supporting customers, patients, staff, and clinics to ensure there is no disruption in current or potential Fresenius Kidney Care Home patients receiving their peritoneal dialysis care. FME has a plan in place to monitor and...Read more

2024 05 Mar

  Divestment of assets includes four separate country transactions to DaVita Inc. for USD 300 million  Transactions further reduce the Company`s clinic footprint in Latin America, following the exit from Argentina at the end of 2023  Expected to close throughout 2024  Proceeds to be used to reduce debt     Fresenius...Read more

2024 20 Feb

  Revenue growth of 5% in 2023 driven by favorable business development Operating income 1 growth of 15% exceeding top end of outlook range, due to business growth, FME25 savings ahead of plan and contributions from the Tricare settlement Successful execution on turnaround plan resulting in significant labor productivity improvements in...Read more